HOW WE HELP
NET Cancer is the FASTEST growing class of CANCER worldwide
HELP US HELP OTHERSNeuroendocrine Tumours (NETs) Overview
- Neuroendocrine tumours (NETs) are abnormal growth of cells (neoplasms) that arise from cells of the diffuse neuroendocrine system.
- NETs are considered complex tumours because both tumor growth and hormonal function must be addressed.
- NETs are most common in the lung or gastrointestinal system, but they can also originate in other parts of the body such as the thyroid, thymus, pancreas, adrenals, paraganglia, ovaries and testes.
- NETs are classified as functional (produce hormones that cause symptoms), or non-functional (may or may not produce hormones and do not cause hormonal symptoms).
- The cause of NETs is currently unknown.
CONTACT US
SUPPORT LINES:
416-628-3189
Toll Free: 1-844-628-6788
EMAIL:
CNETS NEWS
Health Canada Approval of NETSPOT®
Advanced Accelerator Applications Announces Health Canada Approval of NETSPOT® Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours NETSPOT® is the first and only kit for the preparation of gallium (68Ga) oxodotreotide injection for [...]
New Delivery System for Somatuline® Autogel®
Ipsen Announces the Availability of the Newly Designed Delivery System for Somatuline® Autogel® (lanreotide injection) Ipsen Biopharmaceuticals Canada Inc. today announced the availability of a new delivery system for Somatuline® Autogel® (lanreotide injection) 60, 90, [...]
President’s Message – Summer NETNEWS
It is my pleasure to once again share a quick note on the work of CNETS Canada over the past several months. As always, we have been incredibly busy and are happy to report [...]
AWARENESS COMMITTEE / COMITÉ SENSIBILISATION
CNETS Canada is looking for volunteers to join our NET Cancer Awareness Committee. Specific knowledge of NETs or charitable experience is not required but will be considered an asset. We are ideally looking for [...]
68Ga-DOTATATE PET scan in Ontario
68Ga-DOTATATE PET scan in Ontario Cancer Care Ontario has announced that as of April 1st, 2019, Ontario patients with neuroendocrine tumours (NETs) meeting eligibility criteria are able to have their 68Ga-DOTATATE PET scan in Ontario [...]
2019 National NET Patient Conference LIVE-STREAM
Join CNETS Canada 2019 National NET Patient Conference's video & audio conference by clicking the following link: https://freeman.meetngreet.ca/join/x1GxoRj3UO 2019 NATIONAL NET PATIENT CONFERENCE LIVE-STREAM Saturday April 6, 2019 from 8:30 am - 4:30 pm [...]
CNETS PRIORITIES
SUPPORT
- In-person peer-led support groups meetings
- Dedicated patient email and phone support
- Online private support groups for patients & caregivers
EDUCATION
- Patient and caregiver education sessions across Canada
- Robust online patient educational resources
- Printed educational resources including the NET Reference Guide
- Annual NET Medical and Scientific Meeting
AWARENESS
- Raise awareness of NET cancer to the general public & the medical community
- Participate in World NET Cancer Day Activities
